Health Condition 1: J309- Allergic rhinitis, unspecified
Conditions
Interventions
Intervention1: LAOOQ SHAMOON: Asl-us-soos nimkofta Glycyrrhiza glabra L. 20gms
2. Maghz-e-Behidana Cydonia oblonga Mill. 20gms
3. Tukhmekhashkhashsafaid Papaver somniferum L. 40gms
4. Samagh-e-arbi Ac
Sponsors
National Institute of Unani Medicine Bangalore
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age between 18-60 years 2. All genders 3. All cases of allergic rhinitis according to ARIA classification 4. Subjects with both intermittent and/or persistent allergic rhinitis and having at least two of the following rhinitis-associated conditions: nasal congestion, rhinorrhea, sneezing and nasal itching. 5. Patients who will give consent and able to do follow up
Exclusion criteria
Exclusion criteria: 1. Subjects having Nasal polyps, Sinusitis, Atrophic rhinitis, Hypertrophied turbinates,Deviated nasal septum, and congenital nasal abnormalities like nasal dermoid cysts, congenital midline nasal masses etc. 2. Subjects with a history of heart diseases, kidney diseases, liver diseases, DM,Malignancy, and severe asthma. 3. Subjects who had received systematically or topically administered corticosteroids, antihistamines, or decongestants 07 days prior to enrolment 4. Personnel who are taking part in other clinical trials 5. Subjects with known allergy from the ingredients of trial interventions 6. Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in Rhino-conjunctivitis Total Symptom Score (RCTSS)Timepoint: 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Reduction in SNOT-22 score 2.Improvement in subjective parameters 3. AECTimepoint: 4 WEEKS | — |
Countries
India
Contacts
Public ContactDr Mohd Riyazuddin
National institute of unani medicine bangalore
Outcome results
None listed